Matthieu Vanhoutte1,2,3, Franck Semah4,5, Xavier Leclerc4,6, Adeline Rollin Sillaire7,8, Alice Jaillard4,5, Grégory Kuchcinski4,6, Xavier Delbeuck8,9, Rachid Fahmi10, Florence Pasquier7,8, Renaud Lopes4,6. 1. Inserm U1171, CHU Lille, University of Lille, F-59000, Lille, France. mvanhoutte@cyceron.fr. 2. Department of Nuclear Medicine, CHU Lille, F-59000, Lille, France. mvanhoutte@cyceron.fr. 3. Department of Neuroradiology, CHU Lille, F-59000, Lille, France. mvanhoutte@cyceron.fr. 4. Inserm U1171, CHU Lille, University of Lille, F-59000, Lille, France. 5. Department of Nuclear Medicine, CHU Lille, F-59000, Lille, France. 6. Department of Neuroradiology, CHU Lille, F-59000, Lille, France. 7. Department of Neurology, CHU Lille, F-59000, Lille, France. 8. Inserm U1171, CHU Lille, Memory Center, DISTALZ, University of Lille, F-59000, Lille, France. 9. Department of Neuropsychology, CHU Lille, F-59000, Lille, France. 10. Siemens Medical Solutions USA, Inc., Molecular Imaging, Knoxville, TN, USA.
Abstract
PURPOSE: To examine and compare longitudinal changes of cortical glucose metabolism in amnestic and non-amnestic sporadic forms of early-onset Alzheimer's disease and assess potential associations with neuropsychological performance over a 3-year period time. METHODS: Eighty-two participants meeting criteria for early-onset (< 65 years) sporadic form of probable Alzheimer's disease and presenting with a variety of clinical phenotypes (47 amnestic and 35 non-amnestic forms) were included at baseline and followed up for 1.44 ± 1.23 years. All of the participants underwent a work-up at baseline and every year during the follow-up period, which includes clinical examination, neuropsychological testing, genotyping, cerebrospinal fluid biomarker assays, and structural MRI and 18F-FDG PET. Vertex-wise partial volume-corrected glucose metabolic maps across the entire cortical surface were generated and longitudinally assessed together with the neuropsychological scores using linear mixed-effects modeling as a function of amnestic and non-amnestic sporadic forms of early-onset Alzheimer's disease. RESULTS: Similar evolution patterns of glucose metabolic decline between amnestic and non-amnestic forms were observed in widespread neocortical cortices. However, only non-amnestic forms appeared to have a greater reduction of glucose metabolism in lateral orbitofrontal and bilateral medial temporal cortices associated with more severe declines of neuropsychological performance compared with amnestic forms. Furthermore, results suggest that glucose metabolic decline in amnestic forms would progress along an anterior-to-posterior axis, whereas glucose metabolic decline in non-amnestic forms would progress along a posterior-to-anterior axis. CONCLUSIONS: We found differences in spatial distribution and temporal trajectory of glucose metabolic decline between amnestic and non-amnestic early-onset Alzheimer's disease groups, suggesting that one might want to consider treating the two forms of the disease as two separate entities.
PURPOSE: To examine and compare longitudinal changes of cortical glucose metabolism in amnestic and non-amnestic sporadic forms of early-onset Alzheimer's disease and assess potential associations with neuropsychological performance over a 3-year period time. METHODS: Eighty-two participants meeting criteria for early-onset (< 65 years) sporadic form of probable Alzheimer's disease and presenting with a variety of clinical phenotypes (47 amnestic and 35 non-amnestic forms) were included at baseline and followed up for 1.44 ± 1.23 years. All of the participants underwent a work-up at baseline and every year during the follow-up period, which includes clinical examination, neuropsychological testing, genotyping, cerebrospinal fluid biomarker assays, and structural MRI and 18F-FDG PET. Vertex-wise partial volume-corrected glucose metabolic maps across the entire cortical surface were generated and longitudinally assessed together with the neuropsychological scores using linear mixed-effects modeling as a function of amnestic and non-amnestic sporadic forms of early-onset Alzheimer's disease. RESULTS: Similar evolution patterns of glucose metabolic decline between amnestic and non-amnestic forms were observed in widespread neocortical cortices. However, only non-amnestic forms appeared to have a greater reduction of glucose metabolism in lateral orbitofrontal and bilateral medial temporal cortices associated with more severe declines of neuropsychological performance compared with amnestic forms. Furthermore, results suggest that glucose metabolic decline in amnestic forms would progress along an anterior-to-posterior axis, whereas glucose metabolic decline in non-amnestic forms would progress along a posterior-to-anterior axis. CONCLUSIONS: We found differences in spatial distribution and temporal trajectory of glucose metabolic decline between amnestic and non-amnestic early-onset Alzheimer's disease groups, suggesting that one might want to consider treating the two forms of the disease as two separate entities.
Authors: Susan M Landau; Danielle Harvey; Cindee M Madison; Robert A Koeppe; Eric M Reiman; Norman L Foster; Michael W Weiner; William J Jagust Journal: Neurobiol Aging Date: 2009-08-05 Impact factor: 4.673
Authors: Jennifer L Whitwell; David T Jones; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Scott A Przybelski; Prashanthi Vemuri; Brian E Gregg; Jeffrey L Gunter; Matthew L Senjem; Ronald C Petersen; Clifford R Jack; Keith A Josephs Journal: Neurobiol Aging Date: 2014-12-16 Impact factor: 4.673
Authors: Hanna Cho; Seun Jeon; Sue J Kang; Jong-Min Lee; Jae-Hong Lee; Geon Ha Kim; Ji Soo Shin; Chi Hun Kim; Young Noh; Kiho Im; Sung Tae Kim; Juhee Chin; Sang Won Seo; Duk L Na Journal: Neurobiol Aging Date: 2013-02-05 Impact factor: 4.673
Authors: Gérard N Bischof; Frank Jessen; Klaus Fliessbach; Julian Dronse; Jochen Hammes; Bernd Neumaier; Oezguer Onur; Gereon R Fink; Juraj Kukolja; Alexander Drzezga; Thilo van Eimeren Journal: Ann Clin Transl Neurol Date: 2016-10-20 Impact factor: 4.511
Authors: Sebastian J Crutch; Jonathan M Schott; Gil D Rabinovici; Melissa Murray; Julie S Snowden; Wiesje M van der Flier; Bradford C Dickerson; Rik Vandenberghe; Samrah Ahmed; Thomas H Bak; Bradley F Boeve; Christopher Butler; Stefano F Cappa; Mathieu Ceccaldi; Leonardo Cruz de Souza; Bruno Dubois; Olivier Felician; Douglas Galasko; Jonathan Graff-Radford; Neill R Graff-Radford; Patrick R Hof; Pierre Krolak-Salmon; Manja Lehmann; Eloi Magnin; Mario F Mendez; Peter J Nestor; Chiadi U Onyike; Victoria S Pelak; Yolande Pijnenburg; Silvia Primativo; Martin N Rossor; Natalie S Ryan; Philip Scheltens; Timothy J Shakespeare; Aida Suárez González; David F Tang-Wai; Keir X X Yong; Maria Carrillo; Nick C Fox Journal: Alzheimers Dement Date: 2017-03-02 Impact factor: 21.566